Option chain shows key data for Kuros Biosciences's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Kuros Biosciences.

Kuros Biosciences (OTC:CSBTF) Stock, Option Chain

Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of innovative products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategy.

News

Intraday Update

Markets

Movers

Trading Ideas

ACEJF

AFGC

AGFMF

AGRX

AGYS

ALAC

AMRC

ANCTF

APMCF

APPF

APYRF

ATRC

BBSRF

BRLXF

CDMGF

CGEN

CGJTF

CGMLF

CSBTF

CTRN

CWCO

CWST

CYDY

CZFS

DCMYY

DEAC

DNKLY

EDPFY

ELVT

EPAY

EPRT

ESINQ

EVRG

EXPO

FCPT

FJTSF

FLXT

GABC

GBBT

GRBK

GSAH

GVDNY

HAPP

HMSVF

HSSHF

HTLF

IESC

IHRT

KNBIF

KNSL

KYOCY

LAUR

LEN-B

MCQEF

MGEE

MINI

MITEY

Blackrock Muni New York Intermediate Duration Fu

Blackrock Muniholdings California Quality Fund

NDAQ

NDSN

Nuveen Insured California Tax-Free Advantage Municipal Fund

Nuveen New Jersey Dividend Advantage Municipal Fund

OBCI

Stocks That Hit 52-Week Highs On Tuesday

ACHN

ADSW

AHPI

ARXRF

ASNB

BCOW

BTBIF

CBCFF

CBLI

CTLT

DLT RESOLUTION INC by DLT Resolution Inc.

DLTI

FTMNF

GCFFF

GJNSY

GLGDF

HBAYF

HTCMF

LAKE

LAND

LGDOF

LGDTF

LLIT

LYTS

Blackrock Muniholdings Investment Quality Fund

Blackrock Muniholdings New York Quality Fund

Blackrock Muniyield Michigan Quality Fund

MMIRF

Blackrock Muniyield Pennsylvania Quality Fund

MRNTF

Blackrock Muniyield New York Quality Fund

Nuveen Insured Tax-Free Advantage Municipal Fund

Nuveen Insured New York Tax-Free Advantage Municipal Fund

NVRO

OCPNY

OPYGY

PCYO

PLHCF

POYYF

QIFTF

QMCO

QTRHF

RWNFF

SNPHF

SPFI

TGLVY

TPRFF

VCNX

WFCF

WOSSF

XPPLF

MZEIQ

ALTKF

PHYS

NNVC

PSTO

FPWM

Stocks That Hit 52-Week Highs On Monday

KUROS BIOSCIENCE ORD NEW by Kuros Bioscience Ltd.

Kuros Biosciences Ltd

Kuros Bioscience reports Q1 results

Kuros Bioscience reports 1H results

Press Releases

Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand

Events

Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference

Earnings

Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update

Kuros Reports 163% Growth in Direct MagnetOs Sales and 153% Increase in Total Medical Device Sales for the Full Year 2023

Annual General Meeting of Kuros Biosciences Approves All Resolutions

Kuros Reports Corporate Highlights as of Q1 2024 Including Increase in Direct MagnetOsTM Sales

Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 Study Outcomes in Spine, Indicating Superiority Over Autograft

Kuros Biosciences Reports First Half of 2024 Results

Kuros Reports 149% Increase in Direct MagnetOs Sales and Exceeds Cash Flow Breakeven in the First Nine Months of 2024

Kuros Biosciences Expands into Extremities Markets

Kuros Biosciences

Comments

Kuros Biosciences

Kuros Biosciences (CSBTF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga